23 results
Clostridium Dificile Risk by Antibiotic Class

Pooled and study-specific risk estimates of community-associated CDI risk by antibiotic
Clostridium Dificile ... community-associated CDI ... #CDifficile #Infection ... #Association #Pharmacology ... #Table #Comparison
Guidelines on Management of Clostridioides difficile Infection (CDI) in Adults
 • Non-Severe CDI
 • Severe CDI
Clostridioides difficile Infection ... (CDI) in Adults ... @DharSaty #Clostridium ... #management #pharmacology ... #treatment
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Clostridioides Difficile Infection ... #1 nosocomial infection ... mg PO qd - If needing ... Clostridioides #Difficile #Clostridium ... infectiousdiseases #IDSA #gastroenterology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Bacterial Enteric Infections ... Clostridium difficile ... Infection (CDI) ... IDSA #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Preventing and Treating ... Penicillium marneffei Infections ... Treating Acute Infection ... IDSA #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
CDiff Guidelines - Table ... Potential Treatment ... Agents for Treatment ... difficile infection ... Episode #Pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Recommendations for Treating ... in HIV-AIDS Treating ... times weekly (CI ... IDSA #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Recommendations for Treating ... mucoadhesive buccal tablet ... chew, or crush tablet ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Recommendations for Treating ... leishmaniasis and CD4 ... Leishmaniasis #Prevention #Treatment ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
Recommendations for Treating ... ART to maintain CD4 ... control of the infection ... opportunistic #infections ... #HIVAIDS #pharmacology